SOLUBLE PROGRAMMED CELL DEATH-1 IN PSORIASIS AND PSORIATIC ARTHRITIS PATIENTS

被引：0
|
作者：
Tabra, S. A. A. [1 ]
Elsharaby, R. [2 ]
Shaker, E. S. E. [3 ]
Moustafa, A. A. [4 ]
Abu-Zaid, M. H. [1 ]
机构：
[1] Tanta Univ, Rheumatol & Rehabil, Fac Med, Tanta, Egypt
[2] Tanta Univ, Clin Pathol, Fac Med, Tanta, Egypt
[3] Tanta Univ, Dermatol & Venereol, Fac Med, Tanta, Egypt
[4] Al Azhar Univ, Rheumatol & Rehabil, New Damietta Branch, Dumyat, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis;
D O I：
10.1136/annrheumdis-2023-eular.399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1155
引用
收藏
页码：1807 / 1807
页数：1
相关论文
共 50 条
  • [21] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [22] Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
    Chen, Kaiyan
    Cheng, Guoping
    Zhang, Fanrong
    Zhang, Nan
    Li, Dan
    Jin, Jiaoyue
    Wu, Junzhou
    Ying, Lisha
    Mao, Weimin
    Su, Dan
    ONCOTARGET, 2016, 7 (21) : 30772 - 30780
  • [23] Prognostic value of soluble programmed death-1 and soluble programmed death ligand-1 in severe traumatic brain injury patients (vol 14, 23791, 2024)
    Liu, Lei
    Lan, Pengpeng
    Wu, Guiping
    Zhu, Xiaojie
    Shi, Hongfeng
    Li, Yan
    Li, Ruili
    Zhao, Ling
    Xu, Juan
    Xu, Min
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department
    Zhao, Yongzhen
    Jia, Yumei
    Li, Chunsheng
    Fang, Yingying
    Shao, Rui
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (01): : 43 - 48
  • [25] Soluble Programmed Death-1 as a Serum Marker of Poor Liver Function for Hepatocellular Carcinoma Patients
    Chung, Jung Wha
    Park, Dong Won
    Im, Sanghyuk
    Choi, Yun Suk
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    HEPATOLOGY, 2017, 66 : 777A - 777A
  • [26] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu Qiang
    Li Chun-Sheng
    中华医学杂志英文版, 2017, 130 (08) : 986 - 992
  • [27] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu, Qiang
    Li, Chun-Sheng
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 986 - 992
  • [28] Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis
    Greisen, Stinne R.
    Yan, Yan
    Hansen, Aida S.
    Veno, Morten T.
    Nyengaard, Jens R.
    Moestrup, Soren K.
    Hvid, Malene
    Freeman, Gordon J.
    Kjems, Jorgen
    Deleuran, Bent
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [29] Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action
    Zhang, Ni
    Tu, Jingyao
    Wang, Xue
    Chu, Qian
    IMMUNOTHERAPY, 2019, 11 (05) : 429 - 441
  • [30] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
12345